First Tracks Biotherapeutics, Inc. Ordinary Shares (TRAX) Stock Price, Quote & AI Analysis
Live TRAX stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for First Tracks Biotherapeutics, Inc. Ordinary Shares.
TradeVae provides AI-driven analysis and real-time market intelligence for First Tracks Biotherapeutics, Inc. Ordinary Shares (TRAX), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
First Tracks Biotherapeutics, Inc. Ordinary Shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
First Tracks Biotherapeutics, Inc. Ordinary Shares Overview
Company information
Company Overview
First Tracks Biotherapeutics, Inc. engages in the research and development of immunology therapeutics for autoimmune and inflammatory diseases. It focuses on clinical-stage programs for rosnilimab, ANB033 and ANB101. The company is headquartered in San Diego, CA.
Company Details
Technical Indicators
Key technical analysis metrics and indicators
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
First Tracks Biotherapeutics, Inc. Ordinary Shares Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...